Comparison
22q Partial Monosomy C0265489 vs 11q22 2q22 3 Microdeletion Syndrome C5680062
Clinical comparison between 22q Partial Monosomy and 11q22 2q22 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
22q Partial Monosomy C0265489
A genetic disorder from missing material on chromosome 22, often called DiGeorge syndrome. It can affect the heart, immune system, and development. Requires lifelong specialized medical care.
11q22 2q22 3 Microdeletion Syndrome C5680062
A rare genetic condition where a small segment of chromosome 11 is missing. It can affect development and cause various health concerns. Treatment focuses on managing specific symptoms with supportive care.
6 comparison axes
Onset
22q Partial Monosomy C0265489
0-null
11q22 2q22 3 Microdeletion Syndrome C5680062
0-null
Onset patterns differ
Severity
22q Partial Monosomy C0265489
severe
11q22 2q22 3 Microdeletion Syndrome C5680062
moderate
Different severity levels
Chronic
22q Partial Monosomy C0265489
Chronic
11q22 2q22 3 Microdeletion Syndrome C5680062
Chronic
Differing course
Communicable
22q Partial Monosomy C0265489
No
11q22 2q22 3 Microdeletion Syndrome C5680062
No
Different transmission
Body System
22q Partial Monosomy C0265489
congenital
11q22 2q22 3 Microdeletion Syndrome C5680062
congenital
Same/different system
Category
22q Partial Monosomy C0265489
rare-disease
11q22 2q22 3 Microdeletion Syndrome C5680062
genetic
Different category
Bottom line
22q-partial-monosomy-C0265489 and 11q22-2q22-3-microdeletion-syndrome-C5680062 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 22q Partial Monosomy C0265489 | 11q22 2q22 3 Microdeletion Syndrome C5680062 | Discriminating power |
|---|---|---|---|
| Cardiac involvement | Congenital heart anomalies, including conotruncal defects, are recognized but not universal. | A defining cardiac pattern is not established by the supplied description. | Moderate |
| Immune findings | Thymic and T-cell abnormalities may cause variable infection susceptibility. | An immune phenotype is not established from the available source data. | High |
| Development | Developmental, speech, learning, or behavioral concerns may occur with variable severity. | Developmental effects are described, but a specific pattern is not established. | Low |
When to favor each condition
Choose 22q Partial Monosomy C0265489 when
A deletion involving 22q is genetically confirmed.
The chromosomal result identifies the condition rather than symptoms alone.
High
Cardiac, immune, and developmental features suggest 22q testing.
This combination is more characteristic, although overlap and incomplete features occur.
Moderate
Confirmed 22q requires coordinated specialty follow-up.
Cardiac and immune risks may need surveillance beyond developmental support.
Moderate
Choose 11q22 2q22 3 Microdeletion Syndrome C5680062 when
Testing confirms a deletion at 11q22.2-q22.3.
The genomic location distinguishes it from a 22q deletion.
High
Developmental concerns lack established 22q-specific features.
Broad genetic testing is preferable to assuming a 22q diagnosis.
Moderate
Care is organized around individually identified problems.
The supplied evidence supports supportive, symptom-based management.
Moderate
How key tests differ
| Test | 22q Partial Monosomy C0265489 | 11q22 2q22 3 Microdeletion Syndrome C5680062 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May detect missing 22q material; exact result depends on the assay. | May detect the small 11q22.2-q22.3 deletion. | Location and size require laboratory and clinician interpretation. |
| Targeted 22q FISH or MLPA | Can support a targeted 22q finding when the region is covered. | Would not be expected to identify an 11q deletion. | A negative targeted 22q test does not exclude another chromosomal disorder. |
| Cardiac and immune evaluation | May reveal heart or T-cell abnormalities, but normal results do not exclude 22q. | Expected findings are not established from the supplied data. | These assessments guide care; they do not replace genetic diagnosis. |
Prognosis comparison
22q Partial Monosomy C0265489
- Outcome
- Often lifelong and potentially severe, but outcomes vary widely.
- Factors
- Cardiac disease, immune function, development, and access to coordinated care.
11q22 2q22 3 Microdeletion Syndrome C5680062
- Outcome
- Described as moderate, though individual outcome is not established.
- Factors
- Specific developmental and medical findings, plus supportive services.
Time frame: Lifelong; no reliable survival estimate is supplied.
Exact prognosis should not be inferred without individual clinical data.
Complications comparison
| Complication | Presentation |
|---|---|
| Congenital heart disease | A recognized possible complication requiring individualized cardiology care. Not established as characteristic in the supplied description. Do not infer absence or presence without evaluation. |
| Infection susceptibility | Variable immunodeficiency may increase infection risk. Immune complications are not established here. Immune testing and precautions should be clinician-directed. |
| Developmental disability | Learning, speech, or behavioral difficulties may persist. Developmental concerns may occur, with an unspecified range. Early developmental assessment is appropriate for both. |
Patient education highlights
- HighGenetic confirmation
Diagnosis depends on the chromosomal result and clinical interpretation, not symptoms alone.
- HighIndividualized care
Monitoring should follow the person’s confirmed findings, especially heart, immune, growth, and development needs.
- MediumFamily information
Inheritance and recurrence questions require genetic counseling; they cannot be answered from these summaries.